Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
28 results
D1.189 - Does Allergen Immunotherapy Add Clinically Meaningful Benefit in Paediatric Asthma and Allergic Rhinitis? A 36-Month Real-World Comparison
D1.192 - Combined Polymerized Pollen and Animal Dander Immunotherapy Improves Rhinoconjunctivitis and Asthma in Polysensitized Patients: Real-World Evidence
D1.194 - Real-World Effectiveness of Polymerized Dog Allergen Immunotherapy in Allergic Rhinoconjunctivitis and Asthma
D1.195 - Fc-Engagers as a targeted approach for antigen-specific immune inhibition in HDM allergy
D1.197 - Safety and efficacy of a modified one-day ultra-rush protocol for the induction of Hymenoptera venom immunotherapy in patients with anaphylaxis in Switzerland
D1.186 - Three years treatment with HDM injection allergen immunotherapy, omalizumab, or combination therapy in allergic asthma
D1.187 - A Novel Volume-Reduced Desensitization Protocol for Pembrolizumab Hypersensitivity in Advanced Lung Cancer
D1.188 - Adverse Reactions During Honey Bee Venom Immunotherapy as an Indicator of Underlying Clonal Mast Cell Disease Independent of Baseline Serum Tryptase: A Case Report
D1.191 - Respiratory bacterial lysate (OM-85)-loaded dissolving microneedle array patch modulates HDM-induced allergic airway inflammation and airway hyperresponsiveness in a murine asthma model
D1.198 - Efficacy of Cat Allergen Immunotherapy: A Multicenter Prospective Study
D1.199 - Severe vernal keratoconjunctivitis with allergic rhinitis treated with house dust mite (HDM) sublingual immunotherapy (SLIT)
D3.455 - Comparative Characterization of Olfactory Dysfunction in Mouse Models of Eosinophilic Chronic Rhinosinusitis
D3.456 - BEAMER: A multidisciplinary model for disease-agnostic adherence integrating chronic rhinosinusitis: development and prospective study
D3.451 - Long-term follow-up of ASA therapy after desensitization in patients with chronic rhinosinusitis with nasal polyps indicates high rate of treatment discontinuation
D3.454 - Do we still need aspirin desensitization therapy for nasal polyposis?
D3.457 - Does the Way We Ask Matter? Comparing Self- and Interviewer-Administered RQLQ in Allergic Rhinoconjunctivitis
D3.462 - Polysorbate 80 (E433) sensitisation predicts and explains part of the variability of the Chronic Cough and Opposing Defiant Behaviour (ODB) in sensitised children: how the industrialised nutrition impacts the gut-brain axis and favours neuro-inflammation
D3.464 - Influences of Climate and Environmental Exposures on Atopic Dermatitis Persistence and Asthma Development in Early Childhood: 6-Year Follow-up of Longitudinal Study
D3.465 - Climate Change Anxiety Scale (HAES-13) in assessing the emotional impact of extreme weather events
D3.466 - Quantitative assessment of environmental exposure to Der p1, Der p 2 and Der p 23 in European and South African house dust samples
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download